Late Breaking Abstract - Daily physical activity in patients with severe asthma and the effect of anti-IL5 therapy

被引:2
|
作者
Panagiotou, Marios [1 ]
Koulouris, Nikolaos [1 ]
Koutsoukou, Antonia [1 ]
Tsami, Maria [2 ]
Syrigou, Ekaterini [3 ]
Rovina, Nikoletta [1 ]
机构
[1] Univ Athens, Dept Resp Med 1, Sotiria Thorac Dis Gen Hosp, Athens, Greece
[2] Sotiria Gen Hosp, Dept Allergy & Clin Immunol, Athens, Greece
[3] Sotiria Gen Hosp, Dept Allergy & Clin Immunol, Athens, Greece
关键词
Asthma; -; management; Physical activity; Adults;
D O I
10.1183/13993003.congress-2019.PA1648
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA1648
引用
收藏
页数:2
相关论文
共 49 条
  • [21] Anti-IL5 /Rituximab Therapy for Patients suffering from therapy-refractory Eosinophilic Granulomatosis with Polyangiitis
    Gysan, Maximilian Robert
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 601 - 601
  • [22] Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthma
    Kuprys-Lipinska, Izabela
    Majak, Pawel
    Tyrak, Katarzyna Ewa
    Molinska, Joanna
    Kurmanowska, Zofia
    Zal, Aleksandra
    Krzyzanowski, Damian
    Jonakowski, Mateusz
    Mastalerz, Lucyna
    Kuna, Piotr
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [23] LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results
    Bleecker, Eugene
    FitzGerald, J. Mark
    Chanez, Pascal
    Papi, Alberto
    Weinstein, Steve
    Barker, Peter
    Sproule, Stephanie
    Gilmartin, Geoffrey
    Aurivillius, Magnus
    Werkstrom, Viktoria
    Goldman, Mitchell
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [24] LATE-BREAKING ABSTRACT: Increasing physical activity in patients with COPD using a telecoaching program: A multicenter RCT
    Demeyer, Heleen
    Louvaris, Zafeiris
    Tanner, Rebecca
    Rubio, Noah
    Frei, Anja
    de Jong, Corina
    Gimeno Santos, Elena
    Spruyt, Maarten
    Loeckx, Matthias
    Buttery, Sara
    Yerramasu, Claire
    Buesching, Gilbert
    Strassmann, Alexandra
    Serra, Ignasi
    Rabinovich, Roberto
    Vogiatzis, Iannis
    Polkey, Michael
    Garcia Aymerich, Judith
    Troosters, Thierry
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [25] High intensity interval training increases daily life physical activity and quality of life in patients with moderate and severe asthma
    da Silva, Ronaldo Aparecido
    Rocco, Patricia Goncalves Leite
    Mazzucatto, Flavio
    Cukier, Alberto
    Stelmach, Rafael
    Martins, Milton Arruda
    Carvalho, Celso Ricardo Fernandes
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [26] LATE-BREAKING ABSTRACT: Safety and tolerability of once-daily tiotropium Respimat® add-on therapy in children with moderate symptomatic asthma
    Vogelberg, Christian
    Laki, Istvan
    Schmidt, Olaf
    Hamelmann, Eckard
    El Azzi, Georges
    Engel, Michael
    Moroni-Zentgraf, Petra
    Finnigan, Helen
    Vandewalker, Mark
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [27] Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
    Martinez-Moragon, Eva
    Garcia-Moguel, Ismael
    Nuevo, Javier
    Resler, Gustavo
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [28] Effect of dupilumab on improving physical activity in patients with severe asthma
    Sher, Lawrence
    Quirce, Santiago
    Passalacqua, Giovanni
    Taille, Camille
    Cohn, Lauren
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Ortiz, Benjamin
    Khan, Asif H.
    Zhang, Yi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [29] Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
    Eva Martínez-Moragón
    Ismael García-Moguel
    Javier Nuevo
    Gustavo Resler
    BMC Pulmonary Medicine, 21
  • [30] Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study
    Lommatzsch, Marek
    Korn, Stephanie
    Plate, Tanja
    Grund, Thorsten
    Watz, Henrik
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58